ESS vs LAB · P/E 31, rev $1.89B vs rev $174.4M
Essex Property Trust Inc (ESS) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. LAB currently screens at market cap $317.1M.
Not investment advice. Open the ESS and LAB stock pages for the full models.
Not investment advice.